ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors (RIALTO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00458081
Recruitment Status : Terminated (Company decision has been taken in light of recent demands by certain national health authorities)
First Posted : April 9, 2007
Last Update Posted : December 10, 2010
Sponsor:
Information provided by:
Sanofi

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2009
  Actual Study Completion Date : January 2009